Stay updated on Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy
Sign up to get notified when there's something new on the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page.

Latest updates to the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page
- Check6 days agoChange Detected- Revision label updated from v3.6.2 to v3.6.3 on the page. This indicates a minor update to the study page content display.SummaryDifference0.0%

- Check13 days agoChange DetectedThe page's revision label was updated to v3.6.2, indicating a platform or template update rather than changes to the study data. No study content, results, or eligibility information appear to be altered.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now shows that recruitment is closed for the EMBARK study. It also adds navigation/label updates such as How to Read a Study Record, Common Questions, How to Join a Study, and updates the Intervention/Treatment label, along with a new Revision: v3.6.0 tag.SummaryDifference0.3%

- Check35 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a new page build.SummaryDifference0.0%

- Check56 days agoChange DetectedA new revision tag v3.5.4 has been added, replacing v3.5.3. This indicates a minor maintenance update to the page's documentation.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page footer has been updated to reflect a newer ClinicalTrials.gov UI/site revision (v3.5.3 instead of v3.5.2). This represents a site maintenance/version change rather than a change to the study details.SummaryDifference0.0%

Stay in the know with updates to Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page.